RE: Consillium or Numis?13 Dec 2020 16:08
'Fieldfisher's Band-1 ranked Equity Capital Markets team has recently advised Synairgen on its fundraising to support, inter alia, Phase III clinical development and supply chain scale-up of its anti-viral drug SNG001 for COVID-19 patients. The fundraising was structured as a placing to institutional investors in the UK and the US, raising gross proceeds of £80 million for the Company, together with an open offer of up to c. £7 million to its existing shareholders. Numis Securities Limited and finnCap Ltd acted as joint bookrunners on the significantly oversubscribed fundraising.'
There we go again... The Placing was structured to target UK and US Institutional investors...